The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease - Andre F. Batista, Leticia Forny-Germano, Julia R. Clarke, Natalia M. Lyra e Silva, Jordano Brito-Moreira, Susan E. Boehnke, Andrew Winterborn, Brian C. Coe, Ann Lablans, Juliana F. Vital, Suelen A. Marques, Ana M. B Martinez, Matthias Gralle, Christian Holscher, William L. Klein, Jean-Christophe Houzel, Sergio T. Ferreira, Douglas P. Munoz, Fernanda G. De Felice (Wiley-Blackwell, 2018)
6164290